UMC has supported the roll-out of the MedSafety mobile app
to boost ADR reporting in seven countries in collaboration with WHO and the MHRA. The medicines lists from these countries were quality assured before including them in the app. This flowed from the WEB-RADR 2 project, which sought to build on the functionality of the app developed in the original WEB-RADR project sponsored by the Innovative Medicines Initiative.
UMC contributed to 13 training initiatives in Africa, Latin America, Asia and the Mediterranean region, in topics including causality assessment and signal detection, using UMC’s tools VigiFlow and VigiLyze.
An additional e-learning course, Introduction to Pharmacovigilance, was released in both English and Spanish. The new module covers basic concepts as well as the history, need, aims and scope of pharmacovigilance. By June 2020, 8,500 learners had started the course in English, and 2,300 in Spanish, an encouraging response.